Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhongji Longevity Science Group Limited is a Hong Kong-listed company dedicated to the development of a global longevity science ecosystem. The company provides a range of healthcare services including autologous cell therapy, advanced cancer screening, and personalized health management aimed at extending human healthspan. Its business model integrates longevity medicine with financial services to offer comprehensive anti-aging solutions. Zhongji operates specialized laboratory facilities and partners with international research institutions to commercialize longevity-related technologies such as Nicotinamide Mononucleotide (NMN) supplements. The company aims to lead the longevity industry by providing data-driven, personalized wellness programs and early disease detection services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhongji.